AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

1 hour ago 1
ARTICLE AD BOX
Sheer mass helps when enlarged balance sheets allow for bigger bets on potential blockbuster drugs
Read Entire Article
  1. Homepage
  2. category-label-
  3. AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

Related

Boeing clears key hurdle and stock rallies, leading the Dow

Boeing clears key hurdle and stock rallies, leading the Dow

17 minutes ago 0
Micron’s stock sees choppy trading as China fears loom large

Micron’s stock sees choppy trading as China fears loom large...

25 minutes ago 0
If I buy a house for $1 million in cash at 70, will I run out of money by 90?

If I buy a house for $1 million in cash at 70, will I run ou...

48 minutes ago 0
RIGHT SIDEBAR TOP AD

Trending

1. casey mize
2. kris bubic
3. katie boulter
4. rafael jodar
5. liam hicks
6. fritz
7. reid detmers
8. charles iii
9. strait of hormuz transit fees
10. adam macko

Popular

Netflix investors are getting squeamish as Amazon makes inroads in the battle for streaming dominance

Netflix investors are getting squeamish as Amazon makes inro...

1 month ago 6
Jane Street Plans New Data Center as Compute Power Runs Scarce

Jane Street Plans New Data Center as Compute Power Runs Scar...

1 month ago 5
‘This is not a flash in the pan’ — why value stocks are beating growth by such a wide margin

‘This is not a flash in the pan’ — why value stocks are beat...

1 month ago 5
Some singles now expect their dates to pay for their Ubers while gas prices are so high

Some singles now expect their dates to pay for their Ubers w...

1 month ago 4
Here’s how SpaceX is pitching its IPO to everyday investors

Here’s how SpaceX is pitching its IPO to everyday investors

1 month ago 4
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexus Financial News 2026. All rights are reserved